Thread: NTCELL LCT Parkinson’s trial resumes patient recruitment
View Single Post
Old 10-07-2014, 08:07 PM
Tupelo3 Tupelo3 is offline
Member
  
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default LCT announces completion of $3m placement
Living Cell Technologies Limited today announced the placement of 49,410,392 fully paid Ordinary shares at $0.0608 to eligible persons resident in New Zealand, raising $3m. The issue price is a 10% discount to the 5 day volume weighted average closing price to 3 October 2014.

The funds will be used for working capital to continue clinical trials of lead product NTCELL® in Parkinson’s disease and further develop it for other indications.

http://www.scoop.co.nz/stories/BU141...nt-and-spp.htm
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
badboy99 (10-08-2014), lab rat (10-09-2014), soccertese (10-08-2014)